Silverfin false false 30/06/2024 01/07/2023 30/06/2024 Mrs Clare Lashley 22/06/2023 Mr Daniel Lashley 22/06/2023 27 January 2025 The principle activity of the Company during the financial year was the provision of specialist medical practice activities. 14952031 2024-06-30 14952031 bus:Director1 2024-06-30 14952031 bus:Director2 2024-06-30 14952031 core:CurrentFinancialInstruments 2024-06-30 14952031 core:ShareCapital 2024-06-30 14952031 core:RetainedEarningsAccumulatedLosses 2024-06-30 14952031 core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill 2023-06-30 14952031 2023-06-30 14952031 core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill 2024-06-30 14952031 core:OtherPropertyPlantEquipment 2023-06-30 14952031 core:OtherPropertyPlantEquipment 2024-06-30 14952031 bus:OrdinaryShareClass1 2024-06-30 14952031 bus:OrdinaryShareClass2 2024-06-30 14952031 bus:OrdinaryShareClass3 2024-06-30 14952031 bus:OrdinaryShareClass4 2024-06-30 14952031 2023-07-01 2024-06-30 14952031 bus:FilletedAccounts 2023-07-01 2024-06-30 14952031 bus:SmallEntities 2023-07-01 2024-06-30 14952031 bus:AuditExemptWithAccountantsReport 2023-07-01 2024-06-30 14952031 bus:PrivateLimitedCompanyLtd 2023-07-01 2024-06-30 14952031 bus:Director1 2023-07-01 2024-06-30 14952031 bus:Director2 2023-07-01 2024-06-30 14952031 core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill core:TopRangeValue 2023-07-01 2024-06-30 14952031 core:OtherPropertyPlantEquipment core:TopRangeValue 2023-07-01 2024-06-30 14952031 core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill 2023-07-01 2024-06-30 14952031 core:OtherPropertyPlantEquipment 2023-07-01 2024-06-30 14952031 bus:OrdinaryShareClass1 2023-07-01 2024-06-30 14952031 bus:OrdinaryShareClass2 2023-07-01 2024-06-30 14952031 bus:OrdinaryShareClass3 2023-07-01 2024-06-30 14952031 bus:OrdinaryShareClass4 2023-07-01 2024-06-30 iso4217:GBP xbrli:pure xbrli:shares

Company No: 14952031 (England and Wales)

SWNEURO LIMITED

Unaudited Financial Statements
For the financial year ended 30 June 2024
Pages for filing with the registrar

SWNEURO LIMITED

Unaudited Financial Statements

For the financial year ended 30 June 2024

Contents

SWNEURO LIMITED

BALANCE SHEET

As at 30 June 2024
SWNEURO LIMITED

BALANCE SHEET (continued)

As at 30 June 2024
Note 2024
£
Fixed assets
Intangible assets 3 375
Tangible assets 4 6,999
7,374
Current assets
Debtors 5 16,306
Cash at bank and in hand 6 8,754
25,060
Creditors: amounts falling due within one year 7 ( 10,554)
Net current assets 14,506
Total assets less current liabilities 21,880
Net assets 21,880
Capital and reserves
Called-up share capital 8 100
Profit and loss account 21,780
Total shareholders' funds 21,880

For the financial year ending 30 June 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

These financial statements have been prepared in accordance with the provisions of FRS 102 Section 1A – small entities. The financial statements of SWNeuro Limited (registered number: 14952031) were approved and authorised for issue by the Board of Directors on 27 January 2025. They were signed on its behalf by:

Mr Daniel Lashley
Director
SWNEURO LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 30 June 2024
SWNEURO LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 30 June 2024
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year, unless otherwise stated.

General information and basis of accounting

SWNeuro Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is C/O Francis Clark Llp Melville Building East, Unit 18, 23 Royal William Yard, Plymouth, PL1 3GW, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Turnover

Turnover is stated net of VAT and trade discounts and is recognised when the significant risks and rewards are considered to have been transferred to the buyer. Revenue from services is recognised as they are delivered.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on tax rates and laws substantively enacted at the balance sheet date. Deferred tax assets and liabilities are not discounted.

Intangible assets

Intangible assets are stated at cost or valuation, net of amortisation and any provision for impairment. Amortisation is provided on all intangible assets at rates to write off the cost or valuation of each asset over its expected useful life as follows:

Website costs 3 years straight line
Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a [straight-line, reducing balance] basis over its expected useful life, as follows:

Plant and machinery etc. 5 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Profit and Loss Account as described below.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets receivable within one year, such as trade debtors and bank balances, are measured at transaction price less any impairment.

Basic financial assets receivable within more than one year are measured at amortised cost less any impairment.

Financial assets are derecognised when and only when the contractual rights to the cash flows from the financial asset expire or are settled, or the Company transfers to another party substantially all of the risks and rewards of ownership of the financial asset, or the Company, despite having retained some, but not all, significant risks and rewards of ownership, has transferred control of the asset to another party.

Basic financial liabilities
Basic financial liabilities that have no stated interest rate and are payable within one year, such as trade creditors, are measured at transaction price.

Other basic financial liabilities are measured at amortised cost.

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

2. Employees

2024
Number
Monthly average number of persons employed by the Company during the year, including directors 0

3. Intangible assets

Website costs Total
£ £
Cost
At 01 July 2023 0 0
Additions 500 500
At 30 June 2024 500 500
Accumulated amortisation
At 01 July 2023 0 0
Charge for the financial year 125 125
At 30 June 2024 125 125
Net book value
At 30 June 2024 375 375

4. Tangible assets

Plant and machinery etc. Total
£ £
Cost
At 01 July 2023 0 0
Additions 7,559 7,559
At 30 June 2024 7,559 7,559
Accumulated depreciation
At 01 July 2023 0 0
Charge for the financial year 560 560
At 30 June 2024 560 560
Net book value
At 30 June 2024 6,999 6,999

5. Debtors

2024
£
Trade debtors 16,306

6. Cash and cash equivalents

2024
£
Cash at bank and in hand 8,754

7. Creditors: amounts falling due within one year

2024
£
Amounts owed to directors 1,202
Accruals 1,500
Taxation and social security 7,852
10,554

8. Called-up share capital

2024
£
Allotted, called-up and fully-paid
50 Ordinary B shares of £ 1.00 each 50
20 Ordinary C shares of £ 1.00 each 20
20 Ordinary D shares of £ 1.00 each 20
10 Ordinary A shares of £ 1.00 each 10
100